Orbimed Capital Gp IX LLC
CIK 0001920574
Director
Filings
2
Latest Sep 2, 2025
Issuers covered
2
Showing
2 of 2
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +136.4% | +136.4% | +136.4% | +136.4% |
| 90 days | 2 | 100% | +107.2% | +107.2% | +107.2% | +107.2% |
| 180 days | 2 | 100% | +325.6% | +325.6% | +325.6% | +325.6% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Orbimed Capital Gp IX LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| - | Lomond Therapeutics Holdings, Inc. | 1 | Nov 5, 2024 |
| STTK | Shattuck Labs, Inc. | 1 | Sep 2, 2025 |
All filings
2 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|